TrialBMJ (Clinical research ed.)2023

Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.

Yan-Ping Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.